Mde offentlig
[search 0]
Mer
Download the App!
show episodes
 
Artwork

1
MDE Radio

My Digital Enemy

Unsubscribe
Unsubscribe
Månedlig
 
MDE's official monthly podcast (Formerly My Digital Enemy's Zulu Radio). Tune in for exclusives from MDE & Friends. For more info check out www.facebook.com/therealmde
  continue reading
 
Artwork
 
A world traveling pop sensation, an activist for the African Women’s Movements and international tv star is only part of the picture. Vanessa has presented the world with ample proof that she is a powerful woman. You don’t have to be an expert to recognize the polished artistry in these brief clips, songs and speeches. In her own personal podcast, Vanessa brings more of her depth out to the world; through poems, personal stories and inspirational guests. Look into her soul and her story in D ...
  continue reading
 
Loading …
show series
 
To close a beautiful season two, we have Rotimi back on the podcast to discuss with Vanessa about all the elements of an inferiority complex. These two words make up for a lot of holds in personal growth; but how, where does it come from, how can you combat yours? Between Vanessa revealing her childhood insecurities to real advice 50 Cent gave Roti…
  continue reading
 
It is scientifically true that making mistakes grows your brain! Vanesa talks about the change she has been experiencing when it comes to thinking about mistakes because we all think of them as failures versus, "not yets." What a scary and paralyzing thought, right? This science and philosophy combine to help you join the mental movement with Vanes…
  continue reading
 
Today we are taking a moment to reflect on the journey that’s been made. What we are reflecting on today are moments that made a big impact. specifically to the person on the other side of the mic. It is important to take a minute to see what you have accomplished and be grateful for the ups and downs. EP, Amanda Rosenberg who has been teamed up wi…
  continue reading
 
As a child, we’ve all had an adult tell us at one point, “be nice!” Be nice or play nicem, but what if you’re being nice isn’t actually helping anyone? What if it’s even hurting you? On a one on one with Vanessa, she breaks down why you and this world need to stop being nice and start being kind. Is there a difference between the two? Yes, and it's…
  continue reading
 
Part two to help you evaluate and find your excellence with Pearl Thusi jumps right into the ceilings you make for yourself and how that can be a powerful tool to also break them! Pearl reveals her personal goal of trailblazing and hard moments that would put anyone down, but she came back up. The ladies break down what it feels like to stand up fo…
  continue reading
 
Vanessa talks to the star of Netflix’s new hit show Queen Sono, Pearl Thusi! We get a little update on how Pearl has been handling the coronavirus lockdowns. Pearl walks us through her mourning process after losing a loved one. Pearl also gives us some highlights from her career and some of the most influential people she’s met. She also talks abou…
  continue reading
 
The entire world is changing right now! We are all feeling the pressure of where to go for our future, but life pivoriting, career changes and finding happiness within yourself are as common as birthdays. Rotimi drops in on his experience, and Vanessa brings Elle Miss Belle, a beloved family member who grew up with her; a mom, a muse, practically h…
  continue reading
 
Our year is halfway over but the season of the world is clear, 2020 vision as Rotimi would say, clearly the global pandemic has affected every one of you. There is loss and your loss is felt, now how can we turn it into something? What do we do with our lives now? We need to get serious and Vanessa has Rotimi here to discuss their Covid life and th…
  continue reading
 
With all the pandemic and social issues flaring up around the world, you’re on the internet a lot. It’s a staple in your life for good and being honest, probably not so good reasons. A pro to talk about this today is rapper, artist, on-air personality, style icon, multi-award-winning entertainer, and great friend of Vanessa, Nomuzi Mabena. Nomuzi a…
  continue reading
 
“We are all nothing more than children traumatized with longer limbs.” - Faith Kangero. Admitting to trauma is difficult, overcoming it is excruciating, and then the end is a reward of true self-love. Many elements in life, society, or childhood block us. Admitting you need help is hard, and shame fills all of us quickly. However, if the world is t…
  continue reading
 
World-renowned entertainer reveals biggest secrets. Sounds insane right? Are you grabbed? Are you entertained? The business can catch you, SNAP, just like that. However, are you ready for truth that will make you uncomfortable, ugly things that grow under scales? In episodes 2 it’s pulling back the curtain to expose the truly great and powerful Van…
  continue reading
 
Welcome back to season two of Deep Dive with Vanessa Mdee. After a long year of shedding scales and getting her mind vulnerable and ready for a new dawn...Vanessa opens with LOVE. For love is pure, the world needs love right now and God is love. We have Singer/Songwriter and Actor Rotimi to talk about communication in love. You’ve been wondering ho…
  continue reading
 
Today on the podcast, Vanessa brings in Male Super Model and Ivory Coast Man, Adonis Bosso (bio) to help her discuss the stigma around mental health and the reality of recognizing its importance. A hard subject to cover in most communities, but especially in Africa. Adonis himself is uniquely qualified on the subject because of his studies in the f…
  continue reading
 
Today on the podcast, Vanessa brings in her first guest, Ugo Mozie; (bio) to help her discuss the African Influence on Global Culture. Frustrated with African Culture being “trendy” but not properly understood or represented, Ugo and Vanessa share their perspectives while talking about their own life experiences. They also give us a peak behind the…
  continue reading
 
In this premier episode, Vanessa explains her ideas and experiences while embracing the internal magic of being a woman in the modern world. Topics which might bring hesitation from some, but now is a time for understanding. For the first time, you will hear Vanessa speak about taking control of the stage without compromising herself to the demands…
  continue reading
 
ISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in nondiabetics Further analyses from the DAPA-HF trial showed dapagliflozin cut death and heart failure events in HFrEF patients with no d…
  continue reading
 
Vascepa approved for cardiovascular risk reduction The FDA’s decision on cutting events in high-risk patients was based primarily on the REDUCE-IT trial. ENGAGE AF-TIMI: Insulin linked to greater risk for stroke, CV death, bleeding Novel oral anticoagulants may be preferred over warfarin in patients with diabetes and AFib. HHS drug importation prop…
  continue reading
 
Women have fewer cardiovascular events after non–ST-segment elevation ACS But they also remain undertreated with guideline-directed therapies. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * FDA panel rejects vernakalant bid for AFib cardioversion indication El…
  continue reading
 
Icosapent ethyl cost effective in REDUCE-IT analysis Treatment with the fish-derived drug Vascepa for CV event reduction is more effective and less costly than placebo. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * DAPA-HF: Dapagliflozin benefits regardless o…
  continue reading
 
Every great novel and anthology has its beautiful prologue. Singer, Writer, Activist, Global African Flame and much more; Vanessa Mdee brings you the beginning of her tale. This preview is only the start of a long journey into Vanessa’s life, brought continually into the light with her new podcast, Deep Dive with Vanessa Mdee. Subscribe now! Hosted…
  continue reading
 
This week’s Cardiocast is devoted entirely to Card Talk with cardiologist brothers Jim and Jerry Dwyer. They welcome two structural interventionalists at the Structural Heart and Valve Center at Emory Healthcare, Kendra J. Grubb, MD, and Isida Byku, MD. Both followed a unique track, training in both cardiac surgery and interventional cardiology and…
  continue reading
 
In this special meeting edition of the Cardiocast, MDedge Cardiology editor Catherine Hackett is joined by MDedge reporters Mitchel L. Zoler, Bruce Jancin, and Richard Mark Kirkner. The MDedge cardiology team reviews three big stories from the 2019 annual scientific sessions of the American Heart Association in Philadelphia. * * * Help us make this…
  continue reading
 
ISCHEMIA trial hailed as practice changing The largest-ever RCT of initial invasive versus conservative management of stable ischemic heart disease makes waves. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * DAPA-HF: Dapagliflozin’s HFrEF efficacy confirmed in…
  continue reading
 
Getting high heightens stroke, arrhythmia risks Cannabis use or abuse among the young was associated with adverse cardiovascular consequences in two studies. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * Bempedoic acid cuts LDL by 15% in patients with high le…
  continue reading
 
Closing the missing link between childhood risk factors and adult cardiovascular outcomes Prescient childhood cohort studies launched in the 1970s are paying off. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * Metabolic signs of adult diabetes apparent in very…
  continue reading
 
Patients frequently drive too soon after ICD implantation Many patients didn’t recall ever receiving instruction about when to drive again. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * One-third of CVD disease in blacks linked to hypertension A large analysi…
  continue reading
 
Strong showing for TAVR after 5 years in PARTNER 2ATranscatheter and surgical aortic valve replacement had similar rates of death or disabling stroke. * * * Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019 * * * Patiromer allows more CKD patients to continue on spironolacto…
  continue reading
 
Statin use linked to risk of skin and soft tissue infections Use of statins was associated with increased risk of SSTIs at an average of 91, 182, and 365 days. Rivaroxaban trends toward higher thrombotic risk than vitamin K antagonists in APS Patients who took rivaroxaban experienced almost two times as many thrombotic events as patients who took d…
  continue reading
 
Novel cardiac troponin protocol rapidly rules out MI Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission. Study questions preemptive TEVAR for extended type A dissections Interim results from a single-center study show that preemptive TEVAR may not be necessary fo…
  continue reading
 
Smoking and inactivity are the most powerful lifestyle risk factors after an MI Insufficient activity beats out obesity or above-target LDL cholesterol. Ticagrelor monotherapy tops DAPT for high-risk PCI patients TWILIGHT findings support move to shorter dual-antiplatelet therapy. Panel releases guidelines for red meat, processed meat consumption "…
  continue reading
 
Cardiology dead last as women’s IM subspecialty choice Women in internal medicine residencies were more likely than men to report that they had never considered cardiology as a career choice. Beta-blockers effective, safe for HFrEF with renal dysfunction Their role is solidified for essentially all such heart failure patients, regardless of their r…
  continue reading
 
Prasugrel bests ticagrelor in ACS in surprise findings ISAR-REACT 5 was the first-ever direct head-to-head look at two potent P2Y12 inhibitors in this setting. European cholesterol guidelines push LDL targets below 55 mg/dL PCSK-9 inhibitors are elevated to a top-tier recommendation in very-high-risk patients. Drug doses for heart failure could pos…
  continue reading
 
MDedge reporters discuss the latest in practice-changing data from the 2019 annual congress of the European Society of Cardiology in Paris. Join Mitchel L. Zoler, Bruce Jancin, Kari Oakes, and MDedge Cardiology editor Catherine Hackett as they discuss what they reported from the annual meeting.Av MDedge
  continue reading
 
We introduce a brand new format with Jerome Dwyer, MD, brother of our host, Jim Dwyer, MD, for a new segment that we're calling 'Card Talk' where Dr. Jim and Dr. Jerry talk about the current clinical state of cardiology and take a peek into the future. This week in cardiology news: Survival at ‘overweight’ BMI surpasses ‘normal’Data from more than …
  continue reading
 
DAPA-HF results transform dapagliflozin from antidiabetic to heart failure drug Proof that dapagliflozin significantly helped heart failure patients without diabetes recategorizes the drug as a major agent for treating heart failure. New hypertension cases halved with community-wide salt substitution Social marketing principles achieved near-univer…
  continue reading
 
This week in cardiology: PCSK9 inhibition cuts events in very-high-risk groups ODYSSEY OUTCOMES analyses peg prior CABG and polyvascular disease as targets for alirocumab. Cardiovascular cost of smoking may last up to 25 years Past smokers face an elevated cardiovascular risk for up to 25 years after they quit. Impact of climate change on mortality…
  continue reading
 
TAVR valves now FDA approved for low-risk patients The FDA's decision will expand TAVR access to younger, healthier patients. FDA approves baroreflex activation for advanced HF A phase 4 trial will investigate impact on hospitalizations and mortality. Top line results: Dapagliflozin meets primary endpiont in DAPA-HF AstraZeneca announces preliminar…
  continue reading
 
The top news in cardiology: Midlife hypertension linked to dementia risk Elevated blood pressure in midlife is associated with risk of subsequent dementia, but whether the risk is treatable is unclear. Ambulatory BP slightly better than in-office measures for predicting cardiovascular outcomes It’s probably best to save these techniques for specifi…
  continue reading
 
The top stories in cardiology: Artificial intelligence technology meets AFib detection An AI-enabled ECG model suggests clinical implications for early identification of atrial fibrillation. Older patients who stop statins may be increasing their cardiovascular risk Discontinuation of statins was associated with an increased risk of hospital admiss…
  continue reading
 
The top news in cardiology: Meeting just 2 of 7 ‘simple’ goals lowers HF risk American Heart Association recommendations seem to lower risk even if only a couple of the 'Simple 7' are mastered. Increased cardiovascular risk seen early on with testosterone replacement therapy Testosterone replacement therapy for low testosterone is linked to an earl…
  continue reading
 
Statins crush early seizure risk poststroke Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study. Atherosclerotic disease risk persists after smoking cessation Clinicians should reinforce smoking cessation with awareness that risk for several atherosclerotic diseases remains …
  continue reading
 
This week in cardiology: Systolic, diastolic BP each tied to adverse CV outcomes Diastolic hypertension can't be ignored, though systolic ultimately has a larger impact. Almost half of sudden cardiac deaths linked to prior silent MI Prior silent MIs were detected in nearly half of sudden cardiac deaths in people with no coronary artery disease. How…
  continue reading
 
The top stories in cardiology: New findings cast more doubt on fat-but-fit theory Patients who are obese and metabolically healthy face higher cardiac risk Higher omega-3 fatty acid levels cut heart failure risk A large multi-ethnic cohort study shows significantly higher levels of EPA in adults without heart failure. Microvascular disease: An inde…
  continue reading
 
This week's top stories in cardiology: Lipoprotein(a) levels, genes boost ischemic stroke risk Could some elderly skip statins based on negative risk markers? Cardiac events jump after COPD exacerbation CAROLINA findings reaffirm linagliptin’s safety, free glimepiride of CV-risk stigma You can contact the MDedge Cardiocast by emailing us at podcast…
  continue reading
 
This week's top stories in cardiology: FDA Panel: Continue using paclitaxel-eluting PAD Devices, with caveats. Although the benefits of the devices were clear, the panel felt there should be a label change to warn of the late mortality signal seen in a key meta-analysis. Many cardiac cath, electrophysiology lab directors receive big industry paymen…
  continue reading
 
This week's top stories in cardiology: Cognitive decline sped up after CHD Genetic analysis links PCSK9 inhibition and CV mortality Which antidiabetic for elderly patients? It depends on their CV risk Pivotal trial shows HFrEF benefits from baroreceptor stimulation You can contact the Cardiocast by emailing us at podcasts@mdedge.com or you can inte…
  continue reading
 
This week's top stories in Cardiology. Updated systematic review of aspirin primary prevention shows benefits, risks GLP-1 RA dulaglutide yields cardiac gains, even in non–at-risk patients DOACs surpass warfarin in low-weight AFib patients Medicaid expansion associated with lower cardiovascular mortality You can email the show at podcasts@mdedge.co…
  continue reading
 
You can find more of our podcasts at http://www.mdedge.com/podcasts This week in cardiology: FFR changes coronary management in one-third of patients MADIT-CHIC: CRT aids patients with chemotherapy-induced cardiomyopathy Lipoprotein(a) levels can guide CV risk assessment and treatment Cannabis: Doctors tell FDA to get out of the weeds Contact the s…
  continue reading
 
You can find more of our podcasts on our website at http://www.mdedge.com/podcasts. This week in cardiology: Novel cardiogenic shock, PCI protocol nets 72% acute survival Energy drinks increase BP and disrupt the heart's electrical activity Syncope during pregnancy increases risk for poor outcomes Ethnicity seems to affect predisposition to compone…
  continue reading
 
Loading …

Hurtigreferanseguide

Copyright 2024 | Sitemap | Personvern | Vilkår for bruk | | opphavsrett